Clinical Trial

Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 3, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalities of airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. The presence of non-fully reversible airflow obstruction (FEV1/FVC \< 0.7 post-bronchodilation) measured by spirometry confirms the diagnosis of COPD
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-23; most recent amendment 2025-07-30.
Trial Details
NCT Number NCT06518473
Lead Sponsor Mansoura University Hospital
Conditions Chronic Obstructive Pulmonary Disease
Enrollment 50 participants
Start Date 2024-07-14
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-03